SYNERGY™ & SYNERGY MEGATRON™
EES PtCr Coronary Stent System
SYNERGY BP Stent showed numerically lowest ST rates compared to other DES despite being used in patients with more complex disease
| SYNERGY Stent | DES | p | |
|---|---|---|---|
| N patients | 4,247 | 38,110 | <0.01 |
| Class B2/C Lesions | 59% | 54% | <0.01 |
| LM | 6.9% | 6.1% | NS |
| CTO | 4.8% | 4.1% | NS |
| 2VD | 30.0% | 29.4% | NS |
Diabetes | 23.1% | 21.9% | <0.01 |
Prior PCI | 31.2% | 29.2% | <0.01 |
3VD | 17.4% | 16.6% | <0.01 |
Stent Diameter | 2.95 mm | 3.00 mm | <0.01 |
Stent Length | 22.32 mm | 20.32 mm | <0.01 |
SYNERGY BP Stent showed numerically lowest ST rates compared to other new-generation DES despite use in more complex patients with AMI
| SYNERGY BP Stent | n-DES | p | |
|---|---|---|---|
| N patients† | 4,889 | 31,403 |
|
| Previous MI | 24.6% | 22.1% | <0.001 |
| Previous PCI | 21.9% | 19.3% | <0.001 |
| Left Main | 5.5% | 4.8% | 0.026 |
| 3VD | 25.1% | 22.2% | <0.001 |
Restenotic lesion | 6.3% | 4.8% | <0.001 |
Multivessel PCI | 23.9% | 20.7% | <0.001 |
SYNERGY Stent demonstrated the lowest ST rates in patients with ACS
Optimal Healing
Advanced design for optimal healing
Clinical Program
Addressing the full spectrum of cardiovascular disease complexity